{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:09:23Z","timestamp":1787004563672,"version":"build-2736575974"},"reference-count":20,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2004,9,7]],"date-time":"2004-09-07T00:00:00Z","timestamp":1094515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Hintergrund:<\/jats:italic>\n                    Die topische Behandlung ist die Therapie erster Wahl f\u00fcr die milde bis mittelschwer ausgepr\u00e4gte Acne vulgaris. Azelains\u00e4ure ist als 20%ige Cremeformulierung seit 15\u2005Jahren als ein wirksames und sicheres Externum etabliert. Eine neue, nicht\u2010alkoholische Hydrogelformulierung mit 15\u2003% Azelains\u00e4ure wurde klinisch gegen\u00fcber den Standardexterna 5\u2003% Benzoylperoxid (BPO) und 1\u2003% Clindamycin getestet.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Patienten und Methodik:<\/jats:italic>\n                    In zwei unabh\u00e4ngigen, multizentrischen, randomisierten Vergleichsstudien bei 351 und 229\u2005Patienten mit papulopustul\u00f6ser Acne vulgaris wurde das 15\u2003% Azleains\u00e4uregel mit 5\u2003% BPO\u2010 und 1\u2003% Clindamycingel verglichen. Die Medikamente wurden zweimal t\u00e4glich \u00fcber 4 Monate angewendet.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Ergebnisse:<\/jats:italic>\n                    Das Azelains\u00e4uregel erwies sich dabei mit 70 bzw. 71\u2003% prozentualer Reduktion der entz\u00fcndlichen Effloreszenzen (Papeln und Pusteln) als genauso wirksam wie BPO und Clindamycin. Das Azelains\u00e4uregel wurde gut vertragen; die Nebenwirkungen (lokales Brennen und Irritationszeichen) traten deutlich weniger als bei BPO, aber h\u00e4ufiger als bei Clindamycin auf. Trotz der Nebenwirkungen wurde das Azelains\u00e4uregel von der \u00fcberwiegenden Mehrheit der Patienten gut akzeptiert.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Schlu\u00dffolgerungen:<\/jats:italic>\n                    Das Azelains\u00e4uregel stellt eine wirksame topische Monotherapie der milden bis mittelschweren Acne vulgaris dar und ist in der neuen galenischen Formulierung eine Bereicherung in der Therapie der Akne.\n                  <\/jats:p>","DOI":"10.1046\/j.1439-0353.2004.04731.x","type":"journal-article","created":{"date-parts":[[2004,9,7]],"date-time":"2004-09-07T11:42:27Z","timestamp":1094557347000},"page":"841-847","source":"Crossref","is-referenced-by-count":49,"title":["15\u2003% Azelains\u00e4uregel in der Behandlung der Akne. Zwei doppelblinde klinische Vergleichsstudien"],"prefix":"10.1111","volume":"2","author":[{"given":"Harald P. M.","family":"Gollnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Graupe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf\u2010Peter","family":"Zaumseil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,9,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90421-2"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000067820"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.618"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00372056"},{"key":"e_1_2_7_6_2","unstructured":"GloorM KoehlerS FluhrJ. Benzoylperoxid. in: Korting HC Sterry W. Therapeutische Verfahren in der Dermatologie. Berlin: Blackwell 2001: 265\u200a\u2013\u200a272."},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304070-00004"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70177-4"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/120347540100500109"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)70005-8"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6877.555"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","unstructured":"Ross JI Snelling AM Carnegie E Coates P Cunliffe WJ Bettoli V Tosti G Katsambas A Galvan Perez Del Pulgar JI Rollman O Torok L Eady EA Cove JH. Antibiotic\u2010resistant acne. Lessons from Europe. Br J Dermatol 2003; 148: 467\u200a\u2013\u200a478.","DOI":"10.1046\/j.1365-2133.2003.05067.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1996.d01-733.x"},{"key":"e_1_2_7_14_2","unstructured":"GraupeK ZaumseilRP.Skinoren \u2013 ein neues Lokaltherapeutikum zur Behandlung der Acne vulgaris. In: Macher E Kolde G Br\u00f6cker EB. Jahrbuch der Dermatologie 1991\/92 Z\u00fclpich:Biermann 1992:159\u200a\u2013\u200a169."},{"key":"e_1_2_7_15_2","doi-asserted-by":"crossref","unstructured":"Gollnick H Graupe K. Azelaic acid for the treatment of acne: comparative trials. J Dermatol Treatm 1989; 1: 276\u200a\u2013\u200a230.","DOI":"10.3109\/09546638909094478"},{"key":"e_1_2_7_16_2","first-page":"20","article-title":"Efficacy and safety of topical azelaic acid (20 percent cream) an overview of results from European clinical trials and experimental reports","volume":"57","author":"Graupe K","year":"1996","journal-title":"Cutis"},{"key":"e_1_2_7_17_2","unstructured":"GollnickH.Azelains\u00e4ure. In: Korting HC Sterry W. Therapeutische Verfahren in der Dermatologie. Berlin:Blackwell 2001:253\u200a\u2013\u200a264."},{"key":"e_1_2_7_18_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2340\/0001555567116122","article-title":"Azelaic acid vs. placebo: effects on normal human keratinocytes an melanocytes","volume":"67","author":"Mayer\u2010da Silva A","year":"1987","journal-title":"Acta Dermato Venereol (Stockh)"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12277353"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546639109086775"},{"key":"e_1_2_7_21_2","first-page":"538","article-title":"Comparison of combined azelaic acid cream plus oral minocyclin with oral isotretinoin in severe acne","volume":"11","author":"Gollnick H","year":"2001","journal-title":"Eur J Dermatol"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1439-0353.2004.04731.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1439-0353.2004.04731.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T05:00:02Z","timestamp":1697173202000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1439-0353.2004.04731.x"}},"subtitle":["Azelaic acid 15\u2003% gel in the treatment of acne vulgaris. Combined results of two double\u2010blind clinical comparative studies"],"short-title":[],"issued":{"date-parts":[[2004,9,7]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1046\/j.1439-0353.2004.04731.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1439-0353.2004.04731.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,7]]}}}